Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.58    -0.015 (-0.58%)
Bid:
2.585
Ask:
2.59
Spread: 0.005 (0.193%)
Market Cap: $8.51b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Annual Financial Report

3 Apr 2018 07:00

RNS Number : 5215J
Commercial Intnl Bank (Egypt) SAE
01 April 2018
 

 

Commercial International Bank (Egypt) S.A.E.

Consolidated IFRS Financial Statements

December 31, 2017

Click on, or paste the following link into your web browser, to view the associated PDF document.http://www.rns-pdf.londonstockexchange.com/rns/5215J_-2018-4-1.pdf

 

Consolidated statement of profit or loss for the year ended December 31, 2017

Notes

Dec. 31, 2017

Dec. 31, 2016

EGP Thousands

EGP Thousands

Interest and similar income

28,671,170

19,144,218

Interest and similar expense

(16,167,383)

(9,127,195)

Net interest income

3

12,503,787

10,017,023

Fee and commission income

2,676,944

1,965,529

Fee and commission expense

(624,278)

(417,573)

Net fee and commission income

4

2,052,666

1,547,956

Dividend income

5

34,514

34,236

Net trading income

6

1,292,215

1,315,182

Profits (Losses) on financial investments

22

165,111

(25,533)

Goodwill impairment

40

-

(217,078)

Administrative expenses

7

(3,983,324)

(3,119,378)

Other operating expenses

8

(1,059,651)

(1,233,620)

Impairment charge for credit losses

9

(1,742,281)

(892,874)

Intangible Assets amortization

40

-

-

Bank's share in the profits of associates

12

29,066

2,989

Profit before income tax from continuing operations

9,292,103

7,428,903

Current income tax expense

(2,778,973)

(2,017,034)

Deferred income tax

10.2

(1,678)

(76,849)

Net profit from continuing operations

6,511,452

5,335,020

Discontinuing Operations

Profit from discontinuing operations (Net of tax)

39

122,234

127,376

Profit from disposal of discontinuing operations

168,900

-

Net profit for the year

6,802,586

5,462,396

Attributable to:

Equity holders of the parent

6,778,536

5,448,248

Non-controlling interest

24,050

14,148

Net Profit for the year

6,802,586

5,462,396

Earning per share

11

Basic attributable to equity holders of the parent

5.85

4.72

Diluted attributable to equity holders of the parent

5.76

4.65

Earning per share from continuing operations

Basic attributable to equity holders of the parent

5.60

4.61

Diluted attributable to equity holders of the parent

5.51

4.55

The accompying notes from 1 to 41 form an integral part of these consolidated financial statements.

Hisham Ezz Al-Arab

Chairman and Managing Director

Consolidated statement of other comprehensive income for the year ended December 31, 2017

Notes

Dec. 31, 2017

Dec. 31, 2016

 

EGP Thousands

EGP Thousands

 

Profit for the year

6,802,586

5,462,396

 

Other comprehensive income

 

Other comprehensive income to be reclassified to profit or loss in subsequent periods:

 

Net (Loss)/gain on available-for-sale financial assets

537,286

22,219

 

Cumulative foreign currencies translation differences

32

(8,588)

8,588

 

Other comprehensive income for the year

528,698

30,807

 

Total comprehensive income for the year

7,331,284

5,493,203

 

 

Attributable to:

 

Equity holders of the parent

7,307,234

5,479,055

 

Non-controlling interest

24,050

14,148

 

 

The accompanying notes from 1 to 41 form an integral part of these consolidated financial statements.

Consolidated statement of financial position as at December 31, 2017

Notes

Dec. 31, 2017

Dec. 31, 2016

EGP Thousands

EGP Thousands

Assets

Cash and balances with central bank

13

14,663,289

10,522,040

Due from banks

14

45,319,766

58,011,034

Treasury bills and other governmental notes

15

54,478,202

39,177,184

Financial assets held for trading

16

7,295,197

2,445,134

Loans and advances to banks, net

17

1,313

159,651

Loans and advances to customers, net

18

88,427,103

85,224,148

Non current assets held for sale

39

-

4,890,438

Derivative financial instruments

19

40,001

269,269

Financial investments

- Available for sale

21

30,474,781

5,447,291

- Held to maturity

21

45,167,722

53,924,936

Investments in associates and subsidiaries

23

65,039

36,723

Other assets

24

6,886,607

5,434,563

Goodwill

40

-

-

Intangible assets

40

651,041

651,041

Deferred tax assets

10.2

179,630

181,308

Property and equipment

25

1,415,746

1,324,808

Total assets

295,065,437

267,699,568

Liabilities and equity

Liabilities

Due to banks

26

1,877,918

3,008,996

Due to customers

27

250,723,052

231,740,795

Non current liabilities held for sale

39

-

3,684,676

Derivative financial instruments

19

196,984

331,091

Other liabilities

29

6,346,476

4,268,775

Current Tax Liability

2,778,973

2,017,034

Long term loans

28

3,674,736

160,243

Provisions

30

1,615,159

1,514,057

Total liabilities

267,213,298

246,725,667

Equity

Issued and paid in capital

31

11,618,011

11,538,660

Reserves

32

8,867,806

3,448,737

Reserve for employee stock ownership plan (ESOP)

489,334

343,460

Retained earnings

6,876,988

5,509,967

Total equity attributable to equity holders of the parent

27,852,139

20,840,824

Non-controlling interest

-

133,077

Total equity

27,852,139

20,973,901

Total liabilities , equity and non-controlling interest

295,065,437

267,699,568

The accompanying notes from 1 to 41 form an integral part of these consolidated financial statements.

Hisham Ezz Al-Arab

Chairman and Managing Director

 

 

 

Consolidated statement of changes in shareholders' equity

 

Attributable to equity holders of the parents

Dec. 31, 2017

Issued and paid in capital

Reserve for employee stock ownership plan (ESOP)

Retained earnings

Reserves

Total

Non-controlling interest

Total equity

EGP Thousands

Beginning balance

11,470,603

248,148

4,160,601

149,480

16,028,832

47,432

16,076,264

Profit for the year

-

-

5,448,248

-

5,448,248

14,148

5,462,396

Other comprehensive income :

Net (Loss)/gain on available-for-sale financial assets

-

-

-

22,219

22,219

-

22,219

Cumulative foreign currencies translation differences

-

-

-

8,588

8,588

-

8,588

Total comprehensive income

-

-

5,448,248

30,807

5,479,055

14,148

5,493,203

Capital increase

68,057

-

-

-

68,057

-

68,057

Reserve for employee stock ownership plan (ESOP)

-

187,000

-

-

187,000

-

187,000

Dividend

-

-

(1,467,346)

-

(1,467,346)

(1,395)

(1,468,741)

Transferred to reserves

-

(91,688)

(3,176,762)

3,268,450

-

-

-

Change during the year

-

-

545,226

-

545,226

72,892

618,118

Balance at 31 December 2016

11,538,660

343,460

5,509,967

3,448,737

20,840,824

133,077

20,973,901

Profit for the year

-

-

6,778,536.0

-

6,778,536

24,050

6,802,586

Other comprehensive income :

Net (Loss)/gain on available-for-sale financial assets

-

-

-

537,286

537,286

-

537,286

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

Total comprehensive income

-

-

6,778,536

537,286

7,315,822

24,050

7,339,872

Capital increase

79,351

-

-

79,351

-

79,351

Reserve for employee stock ownership plan (ESOP)

-

290,884

-

-

290,884

-

290,884

Dividend

-

-

(1,350,204)

-

(1,350,204)

-

(1,350,204)

Transferred to reserves

-

(145,010)

(4,745,361)

4,890,371

-

-

-

Change during the year

-

-

684,050

-

684,050

(157,127)

526,923

Cumulative foreign currencies translation differences

-

-

-

(8,588)

(8,588)

-

(8,588)

Balance at 31 December 2017

11,618,011

489,334

6,876,988

8,867,806

27,852,139

-

27,852,139

 

 

Consolidated cash flow statement for the year ended December 31, 2017

Notes

Dec. 31, 2017

Dec. 31, 2016

EGP Thousands

EGP Thousands

Cash flow from operating activities

Profit before income tax from continued operations

9,292,103

7,428,903

Profit before income tax from discontinued operations

40

-

158,040

Adjustments to reconcile net profit to net cash provided by operating activities

Fixed assets depreciation

353,681

288,057

Impairment charge for credit losses

1,742,281

892,874

Other provisions charges

212,622

150,847

Trading financial investments revaluation differences

(248,072)

(269,283)

Available for sale and held to maturity investments exchange revaluation differences

100,078

(2,219,961)

Goodwill impairment

-

217,078

Financial investments impairment charge

(83,079)

82,428

Utilization of other provisions

(25,463)

(3,696)

Other provisions no longer used

(97,897)

(78,405)

Exchange differences of other provisions

11,840

583,550

Profits from selling property, plant and equipment

(607)

(1,682)

Profits from selling financial investments

99,047

(35,193)

Profits from selling investments in associates

-

90,447

Shares based payments

290,884

187,000

Bank's share in the profits of associates

(38,636)

(131,799)

Associates financial investments revaluation differences

228

683

Operating profits before changes in operating assets and liabilities

11,609,010

7,339,888

Net decrease (increase) in assets and liabilities

Due from banks

(2,594,442)

264,072

Treasury bills and other governmental notes

(16,466,420)

(16,057,258)

Trading financial assets

(4,601,991)

3,672,526

Derivative financial instruments

95,161

(2,918)

Loans and advances to banks and customers

(4,019,132)

(29,440,654)

Other assets

(1,121,981)

(4,450,111)

Due to banks

(1,131,078)

1,408,227

Due to customers

18,802,058

76,506,379

Income tax obligations paid

(2,017,034)

(1,949,694)

Other liabilities

1,897,201

4,354,673

Net cash provided from operating activities

451,352

41,645,130

Cash flow from investing activities

Proceeds from redemption of subsidiary and associates

750

(12,036)

Payment (proceeds) for purchases and sell of subsidiary and associates

(44,318)

176,161

Payment for purchases of property, plant, equipment and branches constructions

(745,089)

(560,631)

Proceeds from redemption of held to maturity financial investments

13,354,468

4,094

Payment for purchases of held to maturity financial investments

(4,597,254)

(44,667,810)

Payment for purchases of available for sale financial investments

(25,868,230)

(3,334,122)

Proceeds from selling available for sale financial investments

1,261,980

46,370,851

Proceeds from selling non current assets held for sale

628,521

(2,989)

Goodwill impairment

-

-

Non current assets held for sale

428,011

-

Net cash used in investing activities

(15,581,161)

(2,026,482)

Consolidated cash flow statement for the year ended December 31, 2017

(Cont.)

Dec. 31, 2017

Dec. 31, 2016

EGP Thousands

EGP Thousands

Cash flow from financing activities

Increase (decrease) in long term loans

3,524,063

28,915

Dividend paid

(1,350,204)

(1,463,450)

Capital increase

79,351

68,057

Payment related to finanace lease

(3,588)

(12,380)

Net cash used in financing activities

2,249,622

(1,378,858)

Net increase (decrease) in cash and cash equivalent during the year

(12,880,187)

38,239,790

Beginning balance of cash and cash equivalent

52,675,691

14,435,901

Cash and cash equivalent at the end of the year

39,795,504

52,675,691

Cash and cash equivalent comprise:

Cash and balances with central bank

14,663,289

10,522,040

Due from banks

45,319,766

58,011,034

Treasury bills and other governmental notes

54,478,202

39,177,184

Obligatory reserve balance with CBE

(8,878,986)

(5,438,235)

Due from banks with maturities more than three months

(11,132,919)

(11,408,904)

Treasury bills with maturity more than three months

(54,653,848)

(38,187,428)

Total cash and cash equivalent

39,795,504

52,675,691

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR FKDDKCBKKFQK
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.